Antibiotics (Oct 2021)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model

  • Oriana Simonetti,
  • Oscar Cirioni,
  • Gaia Goteri,
  • Guendalina Lucarini,
  • Elżbieta Kamysz,
  • Wojciech Kamysz,
  • Fiorenza Orlando,
  • Giulio Rizzetto,
  • Elisa Molinelli,
  • Gianluca Morroni,
  • Roberto Ghiselli,
  • Mauro Provinciali,
  • Andrea Giacometti,
  • Annamaria Offidani

DOI
https://doi.org/10.3390/antibiotics10101210
Journal volume & issue
Vol. 10, no. 10
p. 1210

Abstract

Read online

Background: LL-37 is the only human antimicrobial peptide that belongs to the cathelicidins. The aim of the study was to evaluate the efficacy of LL-37 in the management of MRSA-infected surgical wounds in mice. Methods: A wound on the back of adult male BALB/c mice was made and inoculated with Staphylococcus aureus. Two control groups were formed (uninfected and not treated, C0; infected and not treated, C1) and six contaminated groups were treated, respectively, with: teicoplanin, LL-37, given topically and /or systemically. Histological examination of VEGF expression and micro-vessel density, and bacterial cultures of wound tissues, were performed. Results: Histological examination of wounds in the group treated with topical and intraperitoneal LL-37 showed increased re-epithelialization, formation of the granulation tissue, collagen organization, and angiogenesis. Conclusions: Based on the mode of action, LL-37 has a potential future role in the management of infected wounds.

Keywords